Cancer

Understanding how an environmental hazard damages DNA may shed light on processes of tumor formation. Read More

(image courtesy of Camp Kesem) Applications are being accepted for Camp Kesem, a free sleep-away camp for children with a parent who has died from cancer, is currently in treatment for cancer or is in remission from cancer. The camp will be held July 22-27 at Camp… Read More

(Vanderbilt University) To help catch head and neck cancer in its earliest stages there will be free cancer screenings at Vanderbilt, Meharry and the Nashville VA on Friday, April 27. Vanderbilt-Ingram Cancer Center, the Vanderbilt Bill Wilkerson Center for Otolaryngology and Communication Sciences, Meharry Medical… Read More

In addition to limited health care resources, biological factors may play a role in the poor survival of children with a common kidney cancer in developing nations. Read More

Measuring levels of an enzyme in head and neck tumors may indicate how the tumor will respond to radiation therapy. Read More

Vanderbilt-Ingram Cancer Center's Green Hills Clinic is located at 3810 Bedford Ave., Suite 100. (Vanderbilt University) Vanderbilt-Ingram Cancer Center will host the community series event “A Taste of Mindfulness” beginning at 6 p.m. Tuesday, April 17, at VICC’s Green Hills clinic, 3810 Bedford Ave., Suite… Read More

Vanderbilt University is already doing genetic analyses of patients to help in developing a shortlist of effective drugs, says Dr. William Schaffner, chairman of the department of preventive medicine at its medical school. Read More

The April program for My Health Chat will be the promising world of cancer drug discovery. Panelists will be Lawrence Marnett, director of the Vanderbilt Institute of Chemical Biology, and Stephen Fesik, director of drug discovery at Vanderbilt-Ingram Cancer Center. They will discuss… Read More

New details on the DNA-cutting activity of topoisomerase II, a target of anti-cancer drugs, could lead to better chemotherapeutic agents. Read More

Investigators from Vanderbilt-Ingram Cancer Center and 12 other centers in the United States and Australia have found that a new drug for patients with metastatic melanoma nearly doubled median overall survival. Read More

When the Nashville Predators hit the ice in Nashville March 10, you can score an assist when it comes to childhood cancer. A portion of the proceeds from the game against the Detroit Red Wings will benefit the Vanderbilt Childhood Cancer Program. A silent auction during the… Read More

Severity of cancer could be predicted by prostate size. Read More

Watch video of Dr. Michael Neuss speaking about the fight against cancer. Neuss spoke Feb. 1 as part of the Osher Lifelong Learning class, “Medical Advances.” The course is presented by faculty of the Vanderbilt University Medical Center and focuses on what the future of medicine holds. Physicians are now able… Read More

Glen and Tracy Parsons (front) and their children (Daniel Dubois/Vanderbilt) At 10:30 p.m., the phone rang and woke Tracy Parsons from a sound sleep. She thought the call must be from her husband, Glen, a truck driver who was on the road that night. But caller ID read “Department… Read More

Individuals who are outside the normal range of expression for the adenomatous polyposis coli (APC) gene have an increased risk of colorectal cancer, according to a study published in the January issue of Gastroenterology. Read More

Investigators at Vanderbilt-Ingram Cancer Center and several other centers may be one step closer to finding out why some melanoma patients relapse after treatment with a promising new drug. Read More

A protein involved in repairing DNA damage associated with gastric reflux may play a tumor suppressor role in the esophagus and could represent a target for therapies to combat esophageal cancer. Read More

In addition to body mass index, genetic markers of obesity may provide value in predicting endometrial cancer risk. Read More

A large, retrospective study of the children of childhood cancer survivors who were treated with radiation therapy and/or some forms of chemotherapy found that the offspring do not have an increased risk for birth defects compared with children of cancer survivors who did not receive these treatments. Read More

Jeffrey Sosman, M.D., professor of Medicine at Vanderbilt-Ingram Cancer Center (VICC), has been named to a melanoma research Dream Team of cancer investigators supported by Stand Up To Cancer (SU2C) and the Melanoma Research Alliance (MRA). Sosman is among the Dream Team’s principal investigators who will work closely with the… Read More